A turning point in hepatology? EASL reflects on the first approved drug for MASH

J Hepatol. 2024 Aug;81(2):192-194. doi: 10.1016/j.jhep.2024.04.036. Epub 2024 May 16.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Drug Approval*
  • Europe
  • Gastroenterology* / methods
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized